Search Results - "Ising, M."

Refine Results
  1. 1

    Cognitive impairment in unipolar depression is persistent and non-specific: further evidence for the final common pathway disorder hypothesis by Reppermund, S, Ising, M, Lucae, S, Zihl, J

    Published in Psychological medicine (01-04-2009)
    “…Cognitive performance is often impaired in depression, and these impairments can persist even after remission from psychopathological symptoms. However, it is…”
    Get more information
    Journal Article
  2. 2

    Evidence for the role of corticotropin-releasing factor in major depressive disorder by Waters, R Parrish, Rivalan, Marion, Bangasser, D A, Deussing, J M, Ising, M, Wood, S K, Holsboer, F, Summers, Cliff H

    Published in Neuroscience and biobehavioral reviews (01-11-2015)
    “…Major depressive disorder (MDD) is a devastating disease affecting over 300 million people worldwide, and costing an estimated 380 billion Euros in lost…”
    Get full text
    Journal Article
  3. 3

    Salivary cortisol response to psychosocial stress in the late evening depends on CRHR1 genotype by Weeger, J., Ising, M., Müller-Myhsok, B., Uhr, M., Schmidt, U., Steiger, A.

    Published in Psychoneuroendocrinology (01-06-2020)
    “…•Variants of CRHR1 rs110402 reveal different cortisol response after psychosocial stress.•Rare homozygous T carrier of CRHR1 rs110402 have significant higher…”
    Get full text
    Journal Article
  4. 4

    FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications by Gassen, N C, Hartmann, J, Zannas, A S, Kretzschmar, A, Zschocke, J, Maccarrone, G, Hafner, K, Zellner, A, Kollmannsberger, L K, Wagner, K V, Mehta, D, Kloiber, S, Turck, C W, Lucae, S, Chrousos, G P, Holsboer, F, Binder, E B, Ising, M, Schmidt, M V, Rein, T

    Published in Molecular psychiatry (01-02-2016)
    “…Psychotropic medications target glycogen synthase kinase 3β (GSK3β), but the functional integration with other factors relevant for drug efficacy is poorly…”
    Get full text
    Journal Article
  5. 5

    Depression, comorbidities and the TNF-α system by Himmerich, H, Fulda, S, Linseisen, J, Seiler, H, Wolfram, G, Himmerich, S, Gedrich, K, Kloiber, S, Lucae, S, Ising, M, Uhr, M, Holsboer, F, Pollmächer, T

    Published in European psychiatry (01-09-2008)
    “…Abstract Depression has frequently been reported to be associated with other physical diseases and changes in the cytokine system. We aimed to investigate…”
    Get full text
    Journal Article
  6. 6

    Ghrelin promotes slow-wave sleep in humans by Weikel, J C, Wichniak, A, Ising, M, Brunner, H, Friess, E, Held, K, Mathias, S, Schmid, D A, Uhr, M, Steiger, A

    “…Ghrelin, an endogenous ligand of the growth hormone (GH) secretagogue (GHS) receptor, stimulates GH release, appetite, and weight gain in humans and rodents…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Increased prevalence of anxiety-associated personality traits in patients with Cushing's disease: a cross-sectional study by Dimopoulou, C, Ising, M, Pfister, H, Schopohl, J, Stalla, G K, Sievers, C

    Published in Neuroendocrinology (01-01-2013)
    “…Chronic hypercortisolism in Cushing's disease (CD) has been suggested to contribute to an altered personality profile in these patients. We aimed to test this…”
    Get more information
    Journal Article
  9. 9

    Delineation of molecular pathway activities of the chronic antidepressant treatment response suggests important roles for glutamatergic and ubiquitin–proteasome systems by Park, D I, Dournes, C, Sillaber, I, Ising, M, Asara, J M, Webhofer, C, Filiou, M D, Müller, M B, Turck, C W

    Published in Translational psychiatry (04-04-2017)
    “…The aim of this study was to identify molecular pathways related to antidepressant response. We administered paroxetine to the DBA/2J mice for 28 days…”
    Get full text
    Journal Article
  10. 10

    HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients by Binder, E.B, Künzel, H.E, Nickel, T, Kern, N, Pfennig, A, Majer, M, Uhr, M, Ising, M, Holsboer, F

    Published in Psychoneuroendocrinology (01-01-2009)
    “…Summary A concatenation of data implicates a hyperactivity of the hypothalamus pituitary adrenal (HPA)-axis in the pathogenesis of depression and its…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disorders by Majer, M, Ising, M, Künzel, H, Binder, E B, Holsboer, F, Modell, S, Zihl, J

    Published in Psychological medicine (01-11-2004)
    “…This study addresses the complex relationship between cognitive function and the course of depression. A sample of patients (n=73) in a depressive episode…”
    Get more information
    Journal Article
  13. 13

    Time experience and time judgment in major depression, mania and healthy subjects. A controlled study of 93 subjects by Bschor, T., Ising, M., Bauer, M., Lewitzka, U., Skerstupeit, M., Müller-Oerlinghausen, B., Baethge, C.

    Published in Acta psychiatrica Scandinavica (01-03-2004)
    “…Objective:  Studies on the time sense of depressed patients have revealed inconsistent results. Manic patients have been almost neglected. Method:  Patients…”
    Get full text
    Journal Article
  14. 14

    Specific behaviour, mood and personality traits may contribute to obesity in patients with craniopharyngioma by Roemmler-Zehrer, J., Geigenberger, V., Störmann, S., Ising, M., Pfister, H., Sievers, C., Stalla, G.K., Schopohl, J.

    Published in Clinical endocrinology (Oxford) (01-01-2015)
    “…Summary Introduction Patients with craniopharyngioma (CP) often suffer from obesity, but the underlying causes are still not fully understood. We compared CP…”
    Get full text
    Journal Article
  15. 15

    A phase I trial of LHC165 single agent and in combination with spartalizumab in patients with advanced solid malignancies by Curigliano, G., Jimenez, M.M., Shimizu, T., Keam, B., Meric-Bernstam, F., Rutten, A., Glaspy, J., Schuler, P.J., Parikh, N.S., Ising, M., Hassounah, N., Wu, J., Leyk, M., Chen, X., Burks, H., Chaudhury, A., Otero, J., Cabanas, E.Garralda

    Published in ESMO open (01-08-2024)
    “…LHC165 is a Toll-like receptor (TLR)-7 agonist that generates an effective tumor antigen-specific T-cell adaptive immune response as well as durable antitumor…”
    Get full text
    Journal Article
  16. 16

    RNA expression profiling in depressed patients suggests retinoid-related orphan receptor alpha as a biomarker for antidepressant response by Hennings, J M, Uhr, M, Klengel, T, Weber, P, Pütz, B, Touma, C, Czamara, D, Ising, M, Holsboer, F, Lucae, S

    Published in Translational psychiatry (31-03-2015)
    “…Response to antidepressant treatment is highly variable with some patients responding within a few weeks, whereas others have to wait for months until the…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Subsided infections and autoimmune events in narcolepsy by Beitinger, P, Ising, M, Kohl, G, Steiger, A

    Published in Sleep medicine (01-12-2013)
    “…Introduction Narcolepsy is a rare sleep–wake disorder characterized by excessive daytime sleepiness with imperative sleep attacks and cataplexy. In the vast…”
    Get full text
    Journal Article